CDK4 and glioblastoma: Highly aggressive tumors are characterized by large increase of catalytically primed states.56 In glioblastoma, driver kinases include EGFR, platelet-derived growth factor receptor α (PDGFRA), and cyclin-dependent kinase 4 (CDK4).